Entering text into the input field will update the search result below

Neurotrope up 4% premarket on NCI agreement

Feb. 04, 2019 9:08 AM ETNeurotrope, Inc. (NTRP) StockBy: Douglas W. House, SA News Editor
  • Thinly traded nano cap Neurotrope (NASDAQ:NTRP) is up 4% premarket on light volume in reaction to its Cooperative Research and Development Agreement with the National Cancer Institute aimed at launching a Phase 1 clinical trial evaluating Bryostatin-1 in children and young adults with CD22-positive leukemia and B-cell lymphoma.
  • NCI's Nirali Shah, M.D. will be lead investigator.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
NTRP--
Neurotrope, Inc.